LCNB Corp’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.27M | Sell |
27,172
-1,215
| -4% | -$140K | 1.1% | 19 |
|
|
2025
Q4 | $2.99M | Sell |
28,387
-929
| -3% | -$87.2K | 1% | 20 |
|
|
2025
Q3 | $2.46M | Sell |
29,316
-796
| -3% | -$65.6K | 0.86% | 22 |
|
|
2025
Q2 | $2.38M | Buy |
30,112
+1,382
| +5% | +$110K | 0.84% | 25 |
|
|
2025
Q1 | $2.58M | Buy |
28,730
+8,877
| +45% | +$829K | 0.95% | 24 |
|
|
2024
Q4 | $1.97M | Buy |
19,853
+700
| +4% | +$72.2K | 0.72% | 32 |
|
|
2024
Q3 | $2.18M | Sell |
19,153
-810
| -4% | -$96.2K | 0.77% | 30 |
|
|
2024
Q2 | $2.47M | Sell |
19,963
-52
| -0.3% | -$6.7K | 0.92% | 25 |
|
|
2024
Q1 | $2.64M | Sell |
20,015
-390
| -2% | -$48.1K | 0.96% | 26 |
|
|
2023
Q4 | $2.22M | Sell |
20,405
-1
| -0% | -$104 | 0.87% | 29 |
|
|
2023
Q3 | $2.1M | Sell |
20,406
-157
| -0.8% | -$16.9K | 0.93% | 25 |
|
|
2023
Q2 | $2.37M | Sell |
20,563
-300
| -1% | -$34.1K | 1.01% | 23 |
|
|
2023
Q1 | $2.22M | Sell |
20,863
-1,370
| -6% | -$148K | 1% | 21 |
|
|
2022
Q4 | $2.47M | Sell |
22,233
-512
| -2% | -$52.3K | 1.15% | 19 |
|
|
2022
Q3 | $1.96M | Buy |
22,745
+626
| +3% | +$55.9K | 1.06% | 22 |
|
|
2022
Q2 | $2.02M | Buy |
22,119
+750
| +4% | +$66.5K | 1.05% | 21 |
|
|
2022
Q1 | $1.75M | Sell |
21,369
-140
| -0.7% | -$11K | 0.82% | 32 |
|
|
2021
Q4 | $1.65M | Buy |
21,509
+9,150
| +74% | +$729K | 0.75% | 34 |
|
|
2021
Q3 | $928K | Buy |
12,359
+990
| +9% | +$75.3K | 0.47% | 63 |
|
|
2021
Q2 | $884K | Buy |
11,369
+1,026
| +10% | +$76.3K | 0.44% | 66 |
|
|
2021
Q1 | $761K | Sell |
10,343
-430
| -4% | -$31.7K | 0.41% | 69 |
|
|
2020
Q4 | $841K | Hold |
10,773
| – | – | 0.48% | 64 |
|
|
2020
Q3 | $853K | Sell |
10,773
-315
| -3% | -$24.7K | 0.56% | 58 |
|
|
2020
Q2 | $818K | Sell |
11,088
-356
| -3% | -$26.8K | 0.55% | 56 |
|
|
2020
Q1 | $840K | Buy |
11,444
+629
| +6% | +$49.4K | 0.66% | 44 |
|
|
2019
Q4 | $938K | Sell |
10,815
-210
| -2% | -$17.2K | 0.57% | 49 |
|
|
2019
Q3 | $886K | Buy |
11,025
+915
| +9% | +$73.3K | 0.57% | 49 |
|
|
2019
Q2 | $809K | Sell |
10,110
-54
| -0.5% | -$4.13K | 0.57% | 53 |
|
|
2019
Q1 | $807K | Hold |
10,164
| – | – | 0.58% | 52 |
|
|
2018
Q4 | $741K | Sell |
10,164
-52
| -0.5% | -$3.67K | 0.61% | 50 |
|
|
2018
Q3 | $692K | Sell |
10,216
-314
| -3% | -$20K | 0.49% | 60 |
|
|
2018
Q2 | $610K | Buy |
10,530
+26
| +0.2% | +$1.47K | 0.55% | 51 |
|
|
2018
Q1 | $546K | Sell |
10,504
-173
| -2% | -$9.34K | 0.49% | 57 |
|
|
2017
Q4 | $574K | Buy |
10,677
+196
| +2% | +$10.9K | 0.51% | 57 |
|
|
2017
Q3 | $641K | Buy |
10,481
+341
| +3% | +$20.7K | 0.6% | 47 |
|
|
2017
Q2 | $620K | Hold |
10,140
| – | – | 0.61% | 51 |
|
|
2017
Q1 | $615K | Sell |
10,140
-159
| -2% | -$9.65K | 0.59% | 51 |
|
|
2016
Q4 | $579K | Buy |
+10,299
| New | +$603K | 0.57% | 53 |
|
Other funds holding MRK
VCM
VPM
LCNB Corp's MRK Position: Q1 2026 in Review
LCNB Corp reduced its Merck (MRK) stake by 4.3% in Q1 2026, selling an estimated $140K and leaving 27,172 shares worth $3.27M. The position accounts for 1.1% of the portfolio, ranked #19.
LCNB Corp first reported a position in MRK in Q4 2016 and has held it in 38 quarters since. 3,775 funds tracked by Wall St. Rank hold MRK as of Q1 2026.
- LCNB Corp held 27,172 shares of Merck worth $3.27M as of Q1 2026.
- LCNB Corp sold 1,215 Merck shares in Q1 2026, an estimated $140K.
- Merck made up 1.1% of LCNB Corp's portfolio in Q1 2026, its #19 holding.
- LCNB Corp first reported a position in Merck in Q4 2016 and has held it in 38 quarters since.
- 3,775 funds tracked by Wall St. Rank held Merck as of Q1 2026.
Based on LCNB Corp's 13F filing for Q1 2026, filed 11 May 2026.